ANAIS YEGHYAIAN: Open Payments
NPI 1790553675 · GLENDALE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$622 in 15 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $168 · 2025 $622
Food & beverage: $622
| Company | Payments | Amount |
|---|---|---|
| Carlsmed, Inc. | 1 | $255 |
| Medtronic, Inc. | 2 | $82 |
| Teva Pharmaceuticals USA, Inc. | 2 | $55 |
| ABBVIE INC. | 2 | $48 |
| Alexion Pharmaceuticals, Inc. | 2 | $46 |
| Lilly USA, LLC | 1 | $32 |
| UCB, Inc. | 2 | $29 |
| Genentech USA, Inc. | 1 | $28 |
| Ethicon US, LLC | 1 | $25 |
| SI-BONE, INC. | 1 | $23 |
Products named: aprevo, STRATA, AUSTEDO XR, QULIPTA, ULTOMIRIS, KISUNLA, Zilbrysq, Ocrevus Zunovo.
Industry payments across CA — which companies pay providers there.
